View Item 

Show simple item record

Effects of restoring portal flow with anticoagulation and partial splenorenal shunt embolization
dc.contributor.authorIntagliata, Nicolas M.en_US
dc.contributor.authorSaad, Wael E.en_US
dc.contributor.authorCaldwell, Stephen H.en_US
dc.date.accessioned2015-03-05T18:24:44Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-03en_US
dc.identifier.citationIntagliata, Nicolas M.; Saad, Wael E.; Caldwell, Stephen H. (2015). "Effects of restoring portal flow with anticoagulation and partial splenorenal shunt embolization." Hepatology 61(3): 1088-1090.en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110757
dc.publisherWiley Periodicals, Inc.en_US
dc.titleEffects of restoring portal flow with anticoagulation and partial splenorenal shunt embolizationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110757/1/hep27241.pdf
dc.identifier.doi10.1002/hep.27241en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceRiggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal‐systemic shunts in persistent hepatic encephalopathy: a case‐control study. Hepatology 2005; 42: 1158 ‐ 1165.en_US
dc.identifier.citedreferenceLaleman W, Simon‐Talero M, Maleux G, Perez M, Ameloot K, Soriano G, et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57: 2448 ‐ 2457.en_US
dc.identifier.citedreferenceZidi SH, Zanditenas D, Gelu‐Simeon M, Rangheard AS, Valla DC, Vilgrain V, et al. Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts. Liver Int 2007; 27: 1389 ‐ 1393.en_US
dc.identifier.citedreferenceSingh S, Kamath PS, Andrews JC, Leise MD. Embolization of spontaneous portosystemic shunts for management of severe persistent hepatic encephalopathy. Hepatology 2014; 59: 735 ‐ 736.en_US
dc.identifier.citedreferenceAn J, Kim KW, Han S, Lee J, Lim YS. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther 2014; 39: 1418 ‐ 1426.en_US
dc.identifier.citedreferenceMukund A, Rajesh S, Arora A, Patidar Y, Jain D, Sarin SK. Efficacy of balloon‐occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol 2012; 23: 1200 ‐ 1206.en_US
dc.identifier.citedreferenceUflacker R, Silva Ade O, d'Albuquerque LA, Piske RL, Mourao GS. Chronic portosystemic encephalopathy: embolization of portosystemic shunts. Radiology 1987; 165: 721 ‐ 725.en_US
dc.identifier.citedreferenceFukuda T, Hirota S, Sugimura K. Long‐term results of balloon‐occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327 ‐ 336.en_US
dc.identifier.citedreferenceAkahane T, Iwasaki T, Kobayashi N, Tanabe N, Takahashi N, Gama H, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon‐occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92: 1026 ‐ 1030.en_US
dc.identifier.citedreferenceCourt FG, Wemyss‐Holden SA, Dennison AR, Maddern GJ. The mystery of liver regeneration. Br J Surg 2002; 89: 1089 ‐ 1095.en_US
dc.identifier.citedreferenceKele PG, de Boer M, van der Jagt EJ, Lisman T, Porte RJ. Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy. Br J Surg 2012; 99: 1113 ‐ 1119.en_US
dc.identifier.citedreferenceShimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997; 26: 343 ‐ 350.en_US
dc.identifier.citedreferenceVilla E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143: 1253 ‐ 1260.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep27241.pdf
Size:
426.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.